On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their vaccine ...

Preclinical Studies Demonstrate Durable Protection Against SARS-CoV-2 Variants, Including Omicron XBB.1.5, Driven by T-Cell ...

In this study, four antigens from SARS-CoV-2 and dengue virus were tested for immunogenicity, antigenicity, allergenicity, and toxicity and chosen to predict dominant T- and B-cell epitopes. Methods: ...

Colombian Presidential candidate Miguel Uribe shot in head during rally. 39-year-old opposition senator Miguel Uribe was shot ...

Years Later is finally about to release, with the franchise's comic cleverly bridging the gap between 28 Days Later and its ...

Data from Two Key Studies Highlight Cross‑Reactivity and Broad‑Spectrum Immunity of GEO-CM04S1 and GeoVax Multi-Antigen Vaccine Technology. ATLANTA, GA - June 4, 2025 (NEWMEDI ...

INTERVIEW: As the zombie franchise keeps regenerating, Danny Boyle sits down with IndieWire for a dive into '28 Years Later.' ...

The fear didn’t come from outside, from the dark or from some monster in the closet. It came from within. From the air. From ...

The Department of Health and Human Services is ending a $766 million contract with the vaccine company Modern to develop an mRNA vaccine for flu strains with pandemic potential, including bird flu.

It was then, even before the most devastating waves of Covid killed millions, that Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, decided to take a bet on an ...

Americans over the age of 65 and those considered at high-risk of contracting the virus will be able to receive an annual COVID-19 vaccine this fall, the essay outlined, while vaccines for low ...